UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice

Pharmaceutics, 2020-09, Vol.12 (9), p.846

2020

Volltextzugriff (PDF)

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults

Clinical pharmacology and therapeutics, 2018-11, Vol.104 (5), p.957-965

2018

Volltextzugriff (PDF)

Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension

Scientific reports, 2019-12, Vol.9 (1), p.19572-10, Article 19572

2019

Volltextzugriff (PDF)

Planning and Conducting a Pharmacogenetics Association Study

Clinical pharmacology and therapeutics, 2021-09, Vol.110 (3), p.688-701

2021

Volltextzugriff (PDF)

A stepwise approach to implementing pharmacogenetic testing in the primary care setting

Pharmacogenomics, 2019-10, Vol.20 (15), p.1103-1112

2019

Volltextzugriff (PDF)

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

Clinical and translational science, 2021-01, Vol.14 (1), p.20-28

2021

Volltextzugriff (PDF)

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A Tutorial

Clinical pharmacology and therapeutics, 2020-09, Vol.108 (3), p.557-565

2020

Volltextzugriff (PDF)

Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers

The pharmacogenomics journal, 2022-02, Vol.22 (1), p.62-68

2022

Volltextzugriff (PDF)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2096

2020

Volltextzugriff (PDF)

Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall

Medicina (Kaunas, Lithuania), 2023-01, Vol.59 (1), p.118

2023

Volltextzugriff (PDF)

Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure Population

Journal of cardiovascular pharmacology, 2020-03, Vol.75 (3), p.250-258

2020

Volltextzugriff (PDF)

Pharmacogenomics of Hypertension and Heart Disease

Current Hypertension Reports, 2015-09, Vol.17 (9), p.586-586, Article 76

2015

Volltextzugriff (PDF)

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2274

2020

Volltextzugriff (PDF)

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network

Pharmacogenomics and personalized medicine, 2020-01, Vol.13, p.217-226

2020

Volltextzugriff (PDF)

Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program

Journal of personalized medicine, 2022-01, Vol.12 (2), p.161

2022

Volltextzugriff (PDF)

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients

Journal of the American Heart Association, 2018-03, Vol.7 (6), p.n/a

2018

Volltextzugriff (PDF)

Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes

Pharmacogenetics and genomics, 2013-12, Vol.23 (12), p.697-705

2013

Volltextzugriff (PDF)

Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients

Pulmonary circulation, 2018-04, Vol.8 (2), p.1-8

2018

Volltextzugriff (PDF)

Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management

Journal of personalized medicine, 2021-05, Vol.11 (6), p.480

2021

Volltextzugriff (PDF)

IGNITE network: Response of patients to genomic medicine interventions

Molecular genetics & genomic medicine, 2019-05, Vol.7 (5), p.e636-n/a

2019

Volltextzugriff (PDF)

Alteration in fasting glucose after prolonged treatment with a thiazide diuretic

Diabetes research and clinical practice, 2014-06, Vol.104 (3), p.363-369

2014

Volltextzugriff (PDF)

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic teaching approach

Journal of clinical and translational science, 2017-09, Vol.1 (S1), p.46-46

2017

Volltextzugriff (PDF)

Abstract 10608: Genome-Wide Association Study Identifies Polymorphisms Associated with Heart Failure Mortality in a Diverse Patient Population

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.675-683

2017

Volltextzugriff (PDF)

Abstract 11877: Beta-blocker Dose Stratifies Both Mortality Risk and Circulating Procollagen Levels In African-Americans With Heart Failure

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A11877-A11877

2016

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults

Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension

Planning and Conducting a Pharmacogenetics Association Study

A stepwise approach to implementing pharmacogenetic testing in the primary care setting

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A Tutorial

Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System

Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall

Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure Population

Pharmacogenomics of Hypertension and Heart Disease

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network

Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients

Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes

Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients

Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management

IGNITE network: Response of patients to genomic medicine interventions

Alteration in fasting glucose after prolonged treatment with a thiazide diuretic

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic teaching approach

Abstract 10608: Genome-Wide Association Study Identifies Polymorphisms Associated with Heart Failure Mortality in a Diverse Patient Population

Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach

Abstract 11877: Beta-blocker Dose Stratifies Both Mortality Risk and Circulating Procollagen Levels In African-Americans With Heart Failure

Suchergebnisse filtern